Education
About Us
Working with TipRanks
Follow Us
Aclarion, Inc. (ACON)
NASDAQ:ACON
ACON Stock Chart & Stats
$5.90
-$0.02(-12.85%)
At close: 4:00 PM EST
$5.90
-$0.02(-12.85%)
Day’s Range― - ―
52-Week Range$5.55 - $3,496.06
Previous Close$0.14
Volume6.36M
Average Volume (3M)272.33K
Market Cap
$4.06M
Enterprise ValueN/A
Total Cash (Recent Filing)$11.34M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.75
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-8258.72
Shares Outstanding671,371
10 Day Avg. Volume781,817
30 Day Avg. Volume272,334
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.13
Price to Sales (P/S)2.69
P/FCF Ratio-0.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$23.00Price Target Upside289.83% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Financial StabilityThe company raised over $20 million in Q1 FY2025 and exited Q2 with $13.4 million in cash, suggesting financial stability and reducing the likelihood of needing additional funding soon.
Market OpportunityAclarion’s addressable market for lower back pain treatment is vast, with an estimated $400 million annual opportunity in the US alone.
Revenue GrowthQ3 revenue growth was driven by an 89% year-over-year increase in Nociscan report volumes.
Bears Say
Operating ExpensesOperating expenses increased significantly, which contributed to a higher net loss for the quarter.
Profit ForecastQ2 FY25 net profit was below forecast due to higher SG&A expenses, which could indicate challenges in managing operational costs.
Aclarion, Inc. News
ACON FAQ
What was Aclarion, Inc.’s price range in the past 12 months?
Aclarion, Inc. lowest stock price was $5.55 and its highest was $3496.06 in the past 12 months.
What is Aclarion, Inc.’s market cap?
Aclarion, Inc.’s market cap is $4.06M.
When is Aclarion, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Aclarion, Inc.’s earnings last quarter?
Currently, no data Available
Is Aclarion, Inc. overvalued?
According to Wall Street analysts Aclarion, Inc.’s price is currently Undervalued.
Does Aclarion, Inc. pay dividends?
Aclarion, Inc. does not currently pay dividends.
What is Aclarion, Inc.’s EPS estimate?
Aclarion, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aclarion, Inc. have?
Aclarion, Inc. has 671,371 shares outstanding.
What happened to Aclarion, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Aclarion, Inc.?
Currently, no hedge funds are holding shares in ACON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Aclarion, Inc.
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
ACON Stock 12 Month Forecast
Average Price Target
$23.00
▲(289.83% Upside)
Technical Analysis
Ownership Overview
9.90% Insiders
0.24% Mutual Funds
1.72% Other Institutional Investors
87.13% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---